pharma · Pancreatic Ductal Adenocarcinoma · Neuroendocrine Tumor Grade 2 · CATX
Perspective Therapeutics
News and analysis for Perspective Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Seattle, USA HQ
2023 Founded
144 Employees
Public company Type
CATX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Seattle, USA
- Founded
- 2023
- Employees
- 144
- Programs
- 6
- Drugs
- 1
- Patents
- 1
News & analysis
NovaPharmaNews articles mentioning Perspective Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Perspective Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.